Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Scientific Reports|September 15, 2016
NOX2 amplifies acetaldehyde-mediated cardiomyocyte mitochondrial dysfunction in alcoholic cardiomyopathyMoritz Brandt, Venkata Garlapati, Matthias Oelze, et al.
Hypertension (Dallas, Tex. : 1979)|July 21, 2022
Telomere Shortening in Hypertensive Heart Disease Depends on Oxidative DNA Damage and Predicts Impaired Recovery of Cardiac Function in Heart FailureMoritz Brandt, Hendrik Dörschmann, Sana'a Khraisat, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2018
Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophyPeggy P Ho, Lauren J Lahey, Foteini Mourkioti, et al.
Cardiovascular Research|July 9, 2018
α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunctionThomas Jansen, Swenja Kröller-Schön, Tanja Schönfelder, et al.
The Journal of Biological Chemistry|August 22, 2014
Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin IISabine Kossmann, Hanhan Hu, Sebastian Steven, et al.
Journal of the American Heart Association|September 1, 2016
Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular DysfunctionSusanne H Karbach, Tanja Schönfelder, Ines Brandão, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2013
Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cellsSabine Kossmann, Melanie Schwenk, Michael Hausding, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 19, 2024
Cerebral vasculitis as clinical manifestation of neuroborreliosis: Pattern of vascular pathology and prognostic factors of outcomeYaroslav Winter, Ole J Simon, Annette Spreer, et al.
The Journal of Clinical Investigation|December 22, 2022
Targeting myeloid cell coagulation signaling blocks MAP kinase/TGF-β1-driven fibrotic remodeling in ischemic heart failureVenkata Garlapati, Michael Molitor, Thomas Michna, et al.
Pageof 6